Cargando…
Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays
BACKGROUND: A challenge for drug of abuse testing is presented by ‘designer drugs’, compounds typically discovered by modifications of existing clinical drug classes such as amphetamines and cannabinoids. Drug of abuse screening immunoassays directed at amphetamine or methamphetamine only detect a s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029917/ https://www.ncbi.nlm.nih.gov/pubmed/24851137 http://dx.doi.org/10.1186/1758-2946-6-22 |